{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P04141",
      "entity_text" : "GM-CSF",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P35354",
      "entity_text" : "COX-2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "A recent study indicated that intratumoral COX-2 inhibition by using parecoxib or valdecoxib potentiates GM-CSF immunotherapy against established mouse GL261 brain tumors.",
  "reading_complete" : "2020-08-04T10:14:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T10:14:05Z",
  "trigger" : "potentiates",
  "evidence" : [ "COX-2 inhibition by using parecoxib or valdecoxib potentiates GM-CSF" ],
  "pmc_id" : "5374396",
  "score" : 0
}